Science Applications International (SAIC) financial statements
Science Applications International reported revenue of $7.3B in fiscal 2026, up 5.6% a year over 9 years.
Net income was $358M and the operating margin 7.2%, against 5.9% in 2017.
Free cash flow was $577M, and the company returned $70M in dividends and $445M in net buybacks.
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from Science Applications International's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4B | $4.5B | $4.7B | $6.4B | $7.1B | $7.4B | $7.7B | $7.4B | $7.5B | $7.3B |
| Cost of revenue | $4.0B | $4.0B | $4.2B | $5.7B | $6.3B | $6.5B | $6.8B | $6.6B | $6.6B | $6.4B |
| Gross profit | $439M | $411M | $464M | $706M | $792M | $859M | $888M | $872M | $892M | $872M |
| Research and development | $4M | $4M | $5M | $7M | $6M | $4M | $1M | $4M | $12M | $13M |
| Selling, general and admin | $166M | $155M | $158M | $288M | $352M | $344M | $374M | $373M | $339M | $350M |
| Operating income | $263M | $256M | $220M | $370M | $390M | $462M | $501M | $741M | $563M | $521M |
| Interest expense | $52M | $44M | $53M | $90M | $122M | $105M | $120M | — | — | — |
| Pre-tax income | $212M | $214M | $170M | $286M | $271M | $358M | $375M | $620M | $428M | $387M |
| Income tax | $69M | $35M | $33M | $57M | $60M | $79M | $72M | $143M | $66M | $29M |
| Net income | $143M | $179M | $137M | $226M | $209M | $277M | $300M | $477M | $362M | $358M |
| EPS (diluted) | $3.12 | $4.02 | $3.11 | $3.83 | $3.56 | $4.77 | $5.38 | $8.88 | $7.17 | $7.70 |
| Diluted shares | 46M | 44M | 44M | 59M | 59M | 58M | 56M | 54M | 50M | 46M |
| Gross margin | 9.9% | 9.2% | 10.0% | 11.1% | 11.2% | 11.6% | 11.5% | 11.7% | 11.9% | 12.0% |
| Operating margin | 5.9% | 5.7% | 4.7% | 5.8% | 5.5% | 6.2% | 6.5% | 10.0% | 7.5% | 7.2% |
| Net margin | 3.2% | 4.0% | 2.9% | 3.5% | 3.0% | 3.7% | 3.9% | 6.4% | 4.8% | 4.9% |
Balance sheet
Fiscal years, from Science Applications International's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $210M | $144M | $237M | $188M | $171M | $106M | $109M | $94M | $56M | $182M |
| Receivables | $539M | $674M | $1.1B | $1.1B | $962M | $1.0B | $936M | $914M | $1.0B | $853M |
| Inventory | $71M | $68M | $74M | $84M | $78M | $64M | $71M | $3M | — | — |
| Total current assets | $901M | $950M | $1.4B | $1.4B | $1.3B | $1.3B | $1.2B | $1.1B | $1.2B | $1.2B |
| Property, plant and equipment | $60M | $61M | $103M | $91M | $108M | $100M | $92M | $91M | $104M | $110M |
| Goodwill | $863M | $863M | $2.1B | $2.1B | $2.8B | $2.9B | $2.9B | $2.9B | $2.9B | $2.9B |
| Total assets | $2.0B | $2.1B | $4.6B | $4.7B | $5.7B | $5.7B | $5.5B | $5.3B | $5.2B | $5.4B |
| Total current liabilities | $623M | $695M | $897M | $1.1B | $1.3B | $1.4B | $1.1B | $1.2B | $1.4B | $982M |
| Long-term debt | $1.0B | $983M | $2.1B | $1.9B | $2.4B | $2.4B | $2.3B | $2.0B | $1.9B | $2.5B |
| Total liabilities | $1.7B | $1.7B | $3.1B | $3.3B | $4.2B | $4.1B | $3.8B | $3.5B | $3.7B | $3.9B |
| Shareholders' equity | $349M | $327M | $1.5B | $1.4B | $1.5B | $1.6B | $1.7B | $1.8B | $1.6B | $1.5B |
| Net debt | $837M | $880M | $1.9B | $1.7B | $2.3B | $2.4B | $2.3B | $2.0B | $2.2B | $2.3B |
Cash flow
Fiscal years, from Science Applications International's 10-K filings with the SEC.
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $273M | $217M | $184M | $458M | $755M | $518M | $532M | $396M | $494M | $609M |
| Capital spending | $15M | $22M | $28M | $21M | $46M | $36M | $25M | $27M | $36M | $32M |
| Free cash flow | $258M | $195M | $156M | $437M | $709M | $482M | $507M | $369M | $458M | $577M |
| Stock-based compensation | $31M | $27M | $45M | $37M | $42M | $46M | $48M | $68M | $53M | $64M |
| Dividends paid | $54M | $54M | $53M | $87M | $87M | $86M | $83M | $79M | $75M | $70M |
| Share buybacks (net) | -$180M | -$186M | -$69M | -$197M | -$34M | -$226M | -$267M | -$382M | -$558M | -$445M |
| Net borrowing | -$27M | -$25M | $1.1B | -$174M | $601M | -$3M | -$150M | -$281M | $118M | $271M |
| Free cash flow margin | 5.8% | 4.4% | 3.3% | 6.9% | 10.0% | 6.5% | 6.6% | 5.0% | 6.1% | 7.9% |
| Dividends per share | $1.18 | $1.21 | $1.20 | $1.47 | $1.48 | $1.48 | $1.49 | $1.47 | $1.49 | $1.51 |
Questions
What was Science Applications International's revenue in 2026?
$7.3B in fiscal 2026, from its 10-K filing.
How much free cash flow does Science Applications International generate?
$577M in fiscal 2026 (operating cash flow minus capital spending).
From Science Applications International's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.